As of 2024-12-12, the Relative Valuation of Constellation Pharmaceuticals Inc (CNST) is (67.82) USD. This relative valuation is based on P/E multiples. With the latest stock price at 33.99 USD, the upside of Constellation Pharmaceuticals Inc based on Relative Valuation is -299.5%.
The range of the Relative Valuation is (63.50) - (59.26) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.6x - 31.4x | 26.5x |
| Forward P/E multiples | 19.1x - 20.1x | 19.6x |
| Fair Price | (63.50) - (59.26) | (67.82) |
| Upside | -286.8% - -274.3% | -299.5% |
| Date | P/E |